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Recent studies with chimeras of hematopoietic and lymphoid system have revealed 
crucial restrictions on cellular interactions and immunologic functions attributable to 
the major histocompatibility  complex (MHC) 1 (1-7).  Most of this work has, thus  far, 
used  models employing semi-allogeneic chimeras or chimeras  in which  graft-vs.-host 
interactions  were either ongoing or a  real possibility  (8, 9). This  has been  necessary 
because of the difficulty of establishing long-lived chimeras between histocompatible 
donors  and  recipients  across  major  histocompatibility  barriers.  When  insufficient 
immunosuppression  (e.g.,  radiation)  is  given,  the  donor  hematopoietic  grafts  are 
rejected  by  classical  immunologic  mechanism  or  do  not  take  as  a  consequence  of 
allogeneic resistance  (10). When sufficient immunosuppression  is given, graft-vs.-host 
reactions  (GVHR)  occur that  are often lethal  (9). Consequently,  to date,  only a  few 
fully allogeneic chimeras  have been studied  (9,  11-17).  As would  be predicted  from 
studies with the semi-allogeneic chimera  (1,  2),  these chimeras  have shown  evidence 
of varying  degrees  in  immunoincompetence,  but  the  studies  are  far from complete. 
Advantage  would  accrue  to  analysis  of  MHC  restrictions  if  healthy  chimeras 
crossing  major  histocompatibility  barriers  could  be produced  and  maintained  over 
long periods  in  which  the  animals  are entirely  free of GVHR.  Such  animals  would 
permit  analysis of the  influence  of thymus  and  thymic epithelium  in  the absence of 
interactions with lymphohematopoietic  cells histocompatible  with donor cells, which 
is unavoidable  in semi-allogeneic chimeras.  Furthermore,  under these circumstances, 
analysis of the influence of incompatibility  of somatic cells with the lymphoreticular 
cells (3) could be examined  in vivo without  complicating consequences  of GVHR. 
The  possibility  of regularly  achieving  models  of full  chimerism  that  cross  major 
histocompatibility barriers was demonstrated  in rats by Miiller-Ruchholtz  et al.  (14), 
who treated fatally irradiated  rats with bone marrow of AgB (major histocompatibil- 
ity system antigen)-incompatible  donors,  using bone marrow that  had  been  exposed 
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in vitro to anti-lymphocyte antiserum appropriately absorbed with both bone marrow 
and  fetal  liver  cells  to  render  it  nontoxic  to  bone  marrow  stem  cells.  Long-lived, 
apparently immunologically vigorous, chimeras were achieved.  Likewise, Truitt  and 
Pollard (15) used germ-free donors and fatally irradiated germ-free recipient mice to 
create  long-lived chimeras  across  major  histocompatibility  barriers.  These  animals 
have been  found to be immunoincompetent in  certain  immunologic responses,  but 
definition of these immunoincompetencies has been difficult because of uncertainty 
concerning the influence of GVHR or adjustments to GVHR. 
Slavin  et  al.  (16)  have  achieved  a  state  of mixed  chimerism  using  total  nodal 
irradiation plus histoincompatible marrow transplantation.  Reisner et al.  (17)  trans- 
planted  stem  cells  isolated  from spleen,  bone marrow, or thymus by agglutination 
and centrifugation after treatment in succession with soybean and peanut lectins and 
achieved  long-lasting chimerism  without  producing GVHR.  Thus  far,  in  none of 
these  models  has  precise  composition  of the  chimeric  state  been  defined  or  has 
comprehensive analysis of the immunocompetence of the chimeras been examined in 
light of the developing evidence of the restrictions imposed on immunologic functions 
by lack of histocompatibility of interacting cells  (8, 9,  11-17). 
It seems especially important to pursue investigations of fully allogeneic chimeras 
because approaches to adoptive immunotherapy (18) may benefit from such analyses. 
In addition,  hematopoietic transplantation  across major histocompatibility barriers 
in  man  offers  attractive  potentialities  for  cellular  engineering  to  treat  inborn  or 
acquired errors of hematopoiesis and abnormalities of immunologic function (19, 20), 
and also offers the possibility of introducing resistance  (R)  genes for treatment  and 
.prevention of occurrence of leukemias,  lymphoid malignancies, and,  perhaps,  other 
cancers (15, 21). 
We report herein preparations of  long-lived chimeras of  AKR recipient and C57BL/ 
6 (B6) donor mice using fatal total body irradiation plus injection of marrow that has 
been  exposed  in  vitro  to  appropriate  anti-Thy-l.2  antiserum  in  the  absence  of 
complement.  When  the  marrow  had  been  treated  with  this  antiserum  in  vitro, 
virtually all  the animals lived in good health  for >  100 d  after the transplant,  and 
evidence of acute GVHR was not seen. 
It is the purpose of this paper to present  an analysis of the cellular makeup of the 
lymphoid tissues,  and to evaluate hematopoietic and immunologic function of these 
radiation chimeras. 
Materials and Methods 
Animals.  Inbred AKR/J, B6, BALB/cgl, and C3H/HeJ were obtained from The Jackson 
Laboratory, Bar  Harbor,  Maine.  B6-H-2  congenic  mice were a  gift  from  Dr.  F.  W.  Shen, 
Memorial  Sloan-Kettering  Cancer Center.  (B6 ×  AKR)F1 and  (B6 ×  BALB/c)F~ mice were 
bred in our colony. 
Preparation of Bone Marrow Chimeras.  Unless stated  otherwise, female AKR mice, 15-wk old, 
were used as irradiated  recipients of marrow cells. The mice were irradiated  in a plastic box 
with  900 rads  using a  ~3VCs-y-irradiation source at  a  dose rate  of 125 rads/min.  24 h after 
irradiation,  these mice were given an intravenous  injection of 25 ×  106 B6 marrow cells treated 
in the following way: donor mice (female B6) were sacrificed by bleeding. Bone marrow cells 
were obtained from tibia  and femur by gently flushing with  cold RPMI-1640 supplemented 
with  heat-inactivated  fetal calf serum  (FCS), 100 IU/ml penicillin,  100 #g/ml streptomycin, 
and glutamine (Grand Island Biological Co., Grand Island, N. Y.). After centrifugation,  marrow 
suspensions were adjusted  to 1 ×  10S/ml and mixed with an equal volume of a  1:5 dilution  of ONOI~, FERNANDES, AND GOOD  117 
a potent anti-Thy-l.2 serum. The cells were incubated with the antiserum on ice for 30 min 
with occasional mixing, washed  three  times with  medium, and injected intravenously into 
lethally irradiated recipients. Complement was not added to this preparation, and the treatment 
did not cause death of the cells at this point because there was no change in trypan blue dye 
exclusion. 
As controls, 25  ×  106 AKR syngeneic or 25  ×  106 unmanipulated B6 marrow cells were 
injected into the irradiated AKR recipients. In some experiments lethally irradiated AKR or 
B6 mice were reconstituted with B6-H-2  k congenic mice (E  k) or B6 marrow cells that had been 
treated with anti-Thy-l.2 serum alone, and irradiated B6 mice were given AKR marrow cells 
treated with anti-Thy-1.1 serum (1:5) without complement as described above. 
All mice were given 400  mg/liter Terramycin (Pfizer  Laboratories, Div. Pfizer Inc., New 
York)  in their drinking water for 2 wk after irradiation. Thereafter, they were maintained on 
a conventional diet and given acidified water ad lib. The mice were observed daily for  100 d. 
For simplicity, chimeras prepared by injecting anti-Thy-1.2 serum-treated B6 marrow cells into 
irradiated AKR mice will be referred to as [B6 ---* AKR] chimeras; AKR mice treated with 
irradiation plus syngeneic cells as [AKR ---* AKR]; B6 mice treated with irradiation plus B6 
cells as [B6 ~  B6]; B6 mice treated with irradiation plus AKR cells as [AKR ----) B6]; and AKR 
mice treated with irradiation plus E  k cells as [E  k ---) AKR]. 
Antisera.  Anti-Thy-l.2 antiserum was prepared by injecting AKR/J female mice with 5 × 
10  v C3H/HeJ  thymus cells  intraperitoneally at  weekly  intervals for  11  wk  (22). To remove 
autoantibody, the serum was absorbed with AKR thymus cells before use. The limiting titer of 
the anti-Thy-l.2 antiserum that gave 50% lysis of B6 thymocytes was between 1/1,600 and 1/ 
3,200, and the titer of anti-Thy-1.1 serum, which was provided by Dr. F. W. Shen, as described 
below, gave 50% lysis of AKR thymocytes at a  titer of I/1,280 and  I/2,560. The following 
antisera were used in typing for H-2 and Thy-I phenotypes. Anti-Thy-l.1 ([B6 ×  A]Fa anti-A- 
Thy- 1.1 congenic mice thymocyte), anti-Thy-  1.2 ([A-Thy-  1.1  ×  AKR-H-2  b congenic mice]F× 
b  k  R  anti-ASLl), anti-H-2  (E  anti-EL-4), and anti-H-2  (hybridoma: 5R3). The antisera used were 
kindly provided  by  Doctors  F.  W.  Shen,  E.  Nakayama,  N.  Tada,  and  U.  Hiimmerling, 
Memorial Sloan-Kettering  Cancer Center. 
Determination of Lymphoid Cell Chimerism.  All chimeras were  maintained without  further 
manipulation after hematopoietic reconstitution for 2.5-3.5 mo before analyses for chimerism 
and immunological functions. Chimerism was tested by analyzing spleen and thymus cells for 
susceptibility to cytolysis by the specific  alloantisera mentioned above plus carefully selected 
rabbit or guinea pig complement. Typing for H-2 and Thy-1 surface antigens was performed 
by the cytotoxic test according to a modification of the method of Gofer and O'Gorman (23). 
Dilutions of antisera used in cytotoxic tests  are indicated in Table I, and, in this condition, 
>95% of relevant target cells and <5% of negative control cells were killed. The percentage of 
dead cells was evaluated by counting labeled cells after addition of 0.2% trypan blue dye. The 
cytotoxic index (CI) was determined according to the following formula: CI equals 
percent killed with antiserum +  complement -  percent killed in complement control 
×  100. 
100 -- percent killed in complement control 
The spleen cell preparations used in each immunological  assay were analyzed for H-2 phenotype 
and in every instance the chimeric spleen cell preparations contaned >95% cells of donor cell 
type. 
Erythrocyte Antibody Complex (EA)-Rosette-forming Cell Assay.  The proportion of the cells that 
possess a receptor for the Fc part ofIgG (FcR) was determined by EA-rosette-forming  cell assay 
as described previously (24). Briefly, sheep erythrocytes (E), sensitized with a subagglutinating 
dose of rabbit anti-sheep IgG (A) were mixed with spleen cells and incubated at 37°C for 5 
rain. After overnight incubation at 4°C, the pellet was  gently resuspended and mixed with 
crystal violet solution (medium 199 that contained 1% glutaraldehyde and 2% crystal violet). 
Stained cells found with three or more EA by light microscopic examination at ×  100 were 
considered rosettes. The results were expressed  as percentages of rosettes  in relation to the total 
number of nucleated cells. 
Simonsen's Splenomegaly Assay.  The assay was performed according to the method by Simon- 
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c)Fx were  gently homogenized and the viable cell  concentration adjusted to  1 X  108/ml  in 
medium 199 that contained 2% FCS.  1 ×  10  7 spleen cells were then injected intraperitoneally 
into littermate 8-d-old (B6 ×  AKR)F1 or (B6 X BALB/c)Fa mice.  8 d later, both spleen-cell 
injected (experimental group) and medium injected (control group) were  killed, their intact 
spleens removed and weighed,  and the spleen index (SI)  calculated (SI: spleen weight/body 
weight).  GVHR index was detected according to the following formula: GVHR index --- SI in 
experimental group/SI in control group. Control mice were thus given a GVHR index of 1.0. 
To determine whether a suppressor cell mechanism participated in [B6 ~  AKR] chimeras, 
1 X  10  7 B6 or AKR spleen cells were mixed with 5 ×  I0  [B6 ~  AKR] or (B6 X AKR)Fx spleen 
cells and injected intraperitoneally into (B6 ×  AKR)Fx littermate mice. 
Mitogen Stimulation.  Details of these assays have been described previously (26). Briefly,  5 
X  106 spleen cells were cultured with 0.25,  1.0, and 5.0/~g of phytohemagglutinin (PHA) per 
milliliter (HA17, Burroughs Wellcome Co.,  Research Triangle Park, N. C.); 0.8,  2.5, and 5.0 
~tg of concanavalin A (Con A) per milliliter (Sigma Chemical Co., St. Louis, Mo.); and 100 #g 
ofEscherichia coh lipopolysaccharide (LPS) per milliliter (Difco Laboratories, Detroit, Mich.) for 
96 h.  16 h before harvest, 0.5 btCi of [methyl-3H]thymidine  (NET-027, New England Nuclear, 
Boston, Mass.)  was added to each culture well. The plates were harvested on glass-fiber  filter 
papers, placed in scintillation fluid, and counted. 
Natural  Killer  (ARK)  Cell  Activity  and  Antibody-dependent  Cell-mediated  Cytotoxicity 
(ADCC).  Spleens from each group of mice were collected in RPMI-1640 supplemented with 
10% FCS (complete medium). The cells were released by gentle teasing in cold media, washed 
three times, and resuspended in complete medium to a concentration of 20 ×  106/ml.  Spleen 
cells from each group of mice to be compared were prepared similarly on the same day. RLc~I 
cells  (radiation-induced leukemia in BALB/c strain) originally obtained from the National 
Institutes of Health (courtesy  of Dr. R. Herberman) were used in NK assay. The NK activity 
was determined by a direct 5aCr-release method as previously described (27). 
The ADCC activity was determined by the method of Perlman as modified by Handwerger 
and Koren (28). Briefly, 50/~1 of varying concentrations of effector cells was added to 50 #1 of 
RPMI-1640 that contained 104 5~Cr-labeled chicken erythrocytes (CRBC) and 100/~1 of a  1/ 
10,000 final dilution of rabbit anti-CRBC antibodies. The plates were  incubated for 3 h  at 
37°C in an atmosphere of 95% air and 5% CO2. The cytotoxicity was determined by a direct 
~lCr-release method. 
Response to In  Vivo Immunization with Sheep Erythrocytes (SRBC).  Each  mouse was  injected 
intraperitoneally with 0.2 ml of a  10% suspension of SRBC (Grand Island Biological Co.). 4 d 
later the spleens were removed, gently homogenized, and the viable cell concentration adjusted 
tO  10  7 cells/ml to measure primary immune response by the plaque-forming cell  (PFC) assay 
previously described (29). To measure secondary immune response,  mice were reimmunized 9 
d after the first injection of SRBC and the PFC assay was carried out on day 13. To enumerate 
IgG  PFC,  rabbit  anti-mouse IgG  plus  guinea pig  complement was  added  in  appropriate 
dilutions. 
In one experiment, spleen cells were treated with anti-H-2  k antibody or anti-H-2  b serum and 
complement before incubating with SRBC on the culture plate (Table IV, footnote). 
Assay for  Contact Sensitivity to  2,4-dinitro-l-fluorobenzene (DNFB)  and Induction of Tolerance to 
DNFB.  DNFB was  obtained from Sigma Chemical Co.  2,4-dinitrobenzene-l-sulfonic  acid 
sodium salt  (DNBS)  was  obtained from  Eastman Kodak Co.,  Rochester,  N.  Y.  Mice were 
sensitized by two daily applications of 25 #1 of 0.5% DNFB in 4:1 acetone:olive oil to the clipped 
skin of the abdominal wall  (30). 4 d  after the last painting, the thickness of both ears was 
measured with an engineer's micrometer as a base-line control. The mice were then challenged 
on the dorsal side of each ear lobe applying 20 #1 of 0.2% DNFB. Ear thickness was remeasured 
24 h after challenge and expressed  as the increase in thickness above base-line control value in 
units of 10  -3 cm ±  SD. Tolerance to DNFB was induced by intravenous injection of DNBS in 
sterile distilled water (750 mg/kg) 7 d before assay according to the method by Phanuphak et 
al. (30). 
Results 
Protection Against  Lethal Irradiation  by Allogeneic  Marrow  Transplantation  with  Marrow 
Cells  Treated  with Anti-Thy-I  Antiserum.  Fig.  1 presents survival curves that compare ONOI~, FERNANDES, AND GOOD  119 
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FIG.  1.  Survival  of chimeras after bone marrow (BM) transplantation. AKR recipients mice were 
lethally irradiated with 900 rads and reconstituted with 25 ×  106 AKR, nontreated B6, and anti- 
Thy-l.2 serum-treated B6  marrow cells. Data pooled from three separate experiments, show 
cumulative mortality after reconstitution with the BM cells. The number in parentheses represents 
the number of animals in each group. Normal AKR: age-matched nontreated AKR female mice. 
3-mo-old female AKR mice treated by 900 rads total body radiation alone, 900 rads 
total body irradiation plus intravenous transplantation of 25 ×  106 marrow cells from 
2-  to  3-mo-old  B6  female  donors,  900  rads  total  body  irradiation  plus  25  ×  106 
syngeneic AKR marrow cells, or 25 X  106 marrow cells from B6 donors that had been 
exposed in vitro to anti-Thy-l.2 antiserum for 30 min before intravenous injection. It 
will be seen  from the Fig.  1 that  both AKR syngeneic marrow transplantation  and 
transplantation of  B6 marrow treated with anti-Thy-1.2 antiserum regularly permitted 
survival  of AKR mice  to  100  d.  By contrast,  80%  of AKR mice  injected  with  B6 
marrow  cells  after  lethal  total  body  irradiation,  although  surviving  longer  than 
irradiated  mice, died within 50 d.  100% of mice given this dose of irradiation  alone 
died within  15 d. 
These findings show that injection of B6 marrow cells  that have been treated with 
anti-Thy-l.2 antiserum without complement protects against lethal irradiation, does 
not  induce GVHR, and permits prolonged survival of the  lethally irradiated  AKR 
mice. 
Chimerism by Allogeneic Marrow Transplantation after Treatment with Anti-Thy-1 Antiserum 
without  Complement.  Table  I  presents  results  comparing representative  observations 
concerning  body weight,  thymus  weight,  numbers  of spleen  cells,  proportions  of 
spleen, and thymus cells bearing H-2 and Thy-1 surface antigens and Fc receptors. It 
will be seen from the table that the [B6 ~  AKR] chimeric mice were generally well 
developed  and  healthy  according  to  their  body  weight  and  by  all  parameters 
compared favorably with irradiated mice reconstituted with syngeneic marrow. The 
numbers  of  spleen  cells  recoverable  from  the  allogeneic  chimeras  were  slightly 
decreased as compared with irradiated mice reconstituted with syngeneic marrow and 
untreated control mice of the same age. Thymus weight also was well  maintained in 
these allogeneic chimeras. Allogeneic chimeras prepared with bone marrow that had 
not been treated with anti-Thy-1 antiserum regularly had only a minisucle thymus or 
the thymus could not be found. It can also be seen from this table that the long-lived 
[B6  ---> AKR]  allogeneic  chimeric  mice  prepared  as  described  are  regularly  full 120  IMMUNE RESPONSES IN FULLY ALLOGENEIC CHIMERA 
TABLE I 
Reconstitution of AKR Mice with Anti-Thy-l.2 Antiserum-treated B6 Bone Marrow Cells 
Group  Age 
Body  Spleen 
Age 
at  Cell  H-2  h  H-2  ~  Thy-l.2 
trans-  FcR 
Weight  Index  num-  (+)  (+)  (+) 
plant  ber  (1/80)  (1/200)  (1/40)  (+) 
Thymus 
Weight 
H_2  h 
(+) 
(1/40) 
Thy-l.2 
(+) 
(1/160) 
Thy-I.l 
(+) 
(I/160)* 
mo  mo  g  %  %  % 
[B6 ~  AKR]  6  3]1  20.2  86¶  98  >95  ** 
24.2  91  68  >95  -- 
25.0  102  73  >95  -- 
23.5  103  128  :>95  -- 
22.5  82  66  :>95  -- 
23.6  87  106  >95  0 
0 
[B6 ---~ Bb]~  6  3  21.1  96  140  :>95  -- 
[AKR ~  AKR]  6  3  26.5  98  102  <5  >95 
Bb~  6  23.1  106  >95  0 
AKR  6  27.6  92  <5  >90 
%  %  mg  %  %  % 
23  77  41  --  :>95  0 
20  68  63  --  >95  0 
15  --  52  :>95  >95  -- 
40  --  58  --  >95  -- 
22  --  --  --  >95  0 
....  0  >95 
33  66  41  :>95  >95  0 
0  61  57  <5  0  :>95 
*  Dilution of antiserum  used in cytotoxic test. See Materials and Methods. 
:~  Syngeneic bone marrow transplantation. 
§  Specificity control for antisera and complement  used  in the cytotoxic test. 
I[  Period after marrow transplantation. 
¶  Body weight  (BW) index  =  BW at assay/BW  at bone marrow transplantation. 
** el. See Materials and Methods. 
:~ Not done. 
chimeras because >95% of their spleen cells or thymus cells were derived from the B6 
donor  marrow.  By  contrast,  no  cells  of spleen  or  thymus  could  be  shown  to  be 
attributable to the recipient's own cell lineages.  In addition, the composition of the 
spleen cells shows slightly lower, but considerable, proportions of T  cells, and these T 
cells  were  entirely  of donor  origin.  These  findings  establish  that  it  is  possible  to 
regularly prepare long-lived chimeras by fatal total body irradiation plus allogeneic 
bone marrow  that has been  treated with anti-Thy-1  antiserum.  The chimeric  mice 
prepared in this way remain in good health and do not show significant evidence of 
stress  as would be revealed  by thymic involution. The method further establishes  a 
state  of full  hematopoietic  and  lymphoid  chimerism  and  that  these  animals  have 
considerable numbers of T  lymphocytes. 
Capacity of Spleen Cells of Allogeneic Chimeras [Bb---~  AKR] to Initiate  GVHR.  Fig.  2 
summarizes  data  comparing  GVHR  initiated  by  spleen  cells  from  [B6  ~  AKR] 
chimeras  with  GVHR  initiated  by  B6  or  (B6  ×  AKR)Fx  or  (B6  X  BALB/c)F1  in 
Simonsen's spenomegaly assay  (25)  in (B6 X AKR)F1 and (B6 X  BALB/c)Fa  recipi- 
ents.  It  will  be  seen  from  Fig.  2  that  [B6 --*  AKR]  chimeric  mice  do  not  initiate 
GVHR  in  (B6  X  AKR)F1  recipients  (Panel  a)  but initiate as vigorous a  GVHR  in 
(B6 X BALB/c)Fx recipients as do spleen cells from intact B6 donors (Panel b). These 
findings establish that the long-lived chimeric [B6 ~  AKR] mice that possess full B6 
lymphoid chimerism are tolerant of both donor and~recipient antigens and responsive 
to third party antigens represented in the BALB/c.  There was a small but significant 
difference  in GVHR  activity between  normal B6 and [B6 ~  AKR]  chimera spleen 
cells when injected into (B6 ×  BALB/c)F1  mice. This difference may also be reflected 
in a slightly lower proportion ofT cells in the spleen cell suspension from the chimeras 
(Table I). 
Absence  of  Development  of  Specific  Suppressor  Phenomenon  in  the  [B6  ~  AKR] RECIPIENT: 
Donor  Cells: 
(lx|O  7 )  0 
B6  spleen  cells 
[B6-" AKR] 
(B6 X AKR)F  I 
(B6 x BALB/c)F I 
Medium 
(o)  (B6 xAKR)F1 
GVHR  Index 
I  I  I 
D 
ONOt~,  FERNANDES,  AND GOOD 
(b)  (B6 x 8ALB/c) F1 
I 
i' 
GVHR  Index 
0  ~  I~  O~  ~  rj~ 
I  i  I  i  i 
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Fro. 2.  Simonsen's splenomegaly assay. 1 X  10  7 spleen cells from B6, [B6 ~  AKR] chimera, (B6 
x  AKR)F1, and medium were injected intraperitoneally into (B6 × AKR)Fa (a), or 1 X 107 cells 
from B6, [B6 --->  AKR], (B6 × BALB/c)F1, and medium into (B6 x BALB/c)F1 littermate mice (b). 
The data show mean GVHR indices ± SD (Materials and Methods). P values from comparison of 
relevant  experiment  and  control  groups  were  ascertained  by Student's t  test.  Significance of 
comparisons between B6, [B6 --~ AKR] chimera, and syngeneic F1 spleen cells injected groups: (a) 
B6, P< 0.0005 for F~; B6, P< 0.0005 for [B6---~  AKR]; all others nonsignificant. (h) B6, P< 0.0005 
for F~; B6, 0.025 <  P <  0.05 for [B6 ---* AKR];  [B6 ~  AKR], P <  0.0005 for F1; all others 
nonsignificant. 
Chimeras.  To  determine  whether  the  tolerant  state  in  [B6  ----> AKR]  chimeras  is 
attributable to a  suppressor cell mechanism, experiments were carried out  in which 
spleen cells of [B6 ~  AKR] chimeras were mixed with either B6 or AKR lymphocytes 
and then injected into (B6 ×  AKR)F1 recipients and evaluated in a  Simonsen's assay 
8  d  later. It will be seen from Fig. 3  that  the capacity of B6 or AKR  spleen cells to 
initiate GVHR  in (B6 ×  AKR)F1 recipients is not inhibited by either the spleen cells 
of the [B6 ~  AKR] chimeras or spleen cells from  (B6 ×  AKR)F1 mice. We interpret 
these findings to establish that a suppressor cell phenomenon does not account for the 
tolerant state of the [B6 ---->  AKR] chimeras spleen cells for either donor or recipient. 
The findings are compatible with the view that the failure of [B6 ~  AKR] chimeric 
cells  to  induce  GVHR  in  the  (B6  ×  AKR)F1  recipient  is  attributable  to  classic 
immunologic tolerance or so-called tolerance by clonal depletion or inhibition (31) or 
immunologic unresponsiveness as exists in (B6 ×  AKR)F1 self tolerance. The tolerant 
state under these circumstances cannot be attributed to a  suppressor cell mechanism 
that involves spleen cells in the chimera. 
Responses of Spleen Cells of[B6---*  AKR] Chimeras to Mitogens.  To evaluate the T-cell 
and  B-celt  reconstitution,  proliferative  responses  of  the  [B6  ~  AKR]  radiation 
chimeras induced by optimal concentrations of PHA, Con A, or LPS were studied. 
Representative  experiments  comparing  responses  to  these  mitogens  of spleen  cells 
from B6, or AKR  mice, [B6 ~  AKR] chimeras and [AKR ~  AKR] and [B6 ~  B6] 
syngeneic marrow  transplanted mice are compared  (Table II). It will be seen  from 
the table that although the proliferative responses to LPS or Con A were significantly 
lower for the [B6 ~  AKR] chimeras than those for AKR  mice, they were comparable 
to those of mice reconstituted by syngeneic marrow transplantation or to B6 donor 
strains. These findings are interpreted as establishing that the [B6 --~ AKR] radiation 
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RECIPIENT:  (B6xAKR)  FI 
Donor  Cells: 
(1 x 10 7 ) +  (5 x I0 s) 
a.  B6  +  (B6x  AKR)Ff 
b.  B6  +  [B6 --=- AKR] 
¢.  [B6"-'~AKR]  (I.5x10  7) 
d.  (B6  x AKR)F t  (I.5x10 7) 
e.  AKR  +  (B6 x AKR)F I 
f.  AKR  +  [B6--AKR] 
g.  (B6xAKR)F,  +  Is6  "-~'AKR] 
h.  Medium 
GVHR  Index 
o  ~  i~  o.l  .I~ 
I  I  I  I  I 
] 
U////////////////////////////////kl 
~/////////////////////A 
O 
F1g.  3.  No influence for GVHR indices of donor (B6) or recipient (AKR) spleen cells in (B6 X 
AKR)Fa mice by adding the cells from [B6 ---* AKR] chimera, i X  10  7 B6 or AKR spleen cells were 
mixed with 5 X 106 {B6---* AKR] chimera or (B6 X AKR)F] spleen  cells  and injected intraperitonealy 
into (B6 X AKR)F] littermate mice (Fig. 2). In groups c and d, 1.5 X 10  v spleen cells from [B6 
AKR] chimeras and (B6 X AKR)FI mice were injected. Statistical comparisons of the GVHR 
indices of the various groups gave the following  P values: a and c, a and d, b and c, and b and d, 
P < 0.005 in all cases; e and g, and e and h, P < 0.0005 in both cases; land g, P< 0.005; and fand 
h, P < 0.01; all others nonsignificant. 
respond by vigorous proliferation to stimulation with mitogens. 
NK Cell and ADCC Activities  in [B6---* AKR] Chimeras.  On Table III are examined 
studies of NK and ADCC activities of spleen cells from AKR, B6, [B6 -* B6] syngeneic 
marrow-reconstituted mice, and [B6---* AKR] chimeras. It will be seen from the table 
that  the NK activities toward RLdl  cells and ADCC activities towards CRBC  are 
comparable at two different effector:target cell ratios in mice of all four groups. These 
findings support the conclusion that the [B6 ---* AKR] chimeras do not differ from the 
donor or recipient strains or from syngeneically reconstituted mice according to these 
immunological parameters. 
PFC Responses  to  In  Vivo Stimulation  with  SRBC  in  [B6 ---*  AKR]  Chimeras.  To 
evaluate capacity for T-cell-dependent antibody production the  response to  SRBC 
after primary antigenic stimulation or secondary stimulation were studied. The results 
of these experiments are summarzed in Table IV. It will be seen from the table that 
the [B6 ---* AKR] chimeras were almost completely unresponsive to primary antigenic 
stimulation with  SRBC  as  might  be  predicted  from  earlier  experiments  in  other 
systems  (1,  2,  5,  11-13).  However,  upon  secondary  stimulation the  [B6---*  AKR] 
chimeras showed a vigorous response in the direct (IgM) PFC assay and also developed 
surprisingly vigorous responses in the indirect PFC assay. The responses of the  [B6 
---* AKR]  chimeras  in  indirect plaque-forming assay  were  significantly lower  than 
those of the AKR, B6, or  [B6 ---* B6]  mice. The direct  PFC responses, on the other 
hand, were significantly greater than those of either AKR, B6,  or  [AKR ---* AKR} 
mice and equal to those of the [B6 ---* B6] mice after secondary stimulation. ONOI~,  FERNANDES, AND GOOD 
TABLE  II 
Spleen Cell Responses to Mitogens m [B6 ~  AKR] Chimeras 
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Group  Control* 
Mitogen~: 
PHA  Con A  LPS 
AKR§ (4)11  3,316 ±  703¶  59,914 ::t: 13,456  103,109  ±  10,900"*  27,602 4- 3,197"* 
B6 (4)  1,297 ±  110  59,597 ±  3,264  80,190 ±  11,420~  20,876  --- 2,459 
[B6 ~  B6] (2)  1,905 ±  769  44,162 ±  3,347  42,533  +  12,944  18,736 4- 3,453 
[B6 ~  AKR] (5)  1,757 ±  507  51,161 ±  11,835  50,157  ±  12,442  20,570 ±  2,378 
*  The background counts in cultures without mitogen. 
PHA, 1.0/~g/ml;  Con A, 2.5/~g/ml; LPS, 10 ~g/ml. 
§  Age-matched nontreated mice. 
II  Number of animals in each group. 
¶  Data is expressed as the average counts per minute of [aH]Tdr ±  SE. 
** Significantly higher than [B6 ~  AKR] (P <  0.01). 
:]::~ Not significantly higher than [B6 --o AKR] (P >  0.05). 
TABLE  III 
NK and ADCC Activity in [B6 --~ AKR] Chimeras 
Group 
NK  ADCC 
Percent specific lysis of 
SlCr.RLdl  51Cr-CRBC 
100:I  25:1  I00:I  25:1 
AKR (3)*  10.25 +  2.65:1:  3.51 -1- 1.28  62.64 ±  4.09  35.21 ±  5.62 
BT (4)  10.24 +  3.77  4.96 +  1.04  33.78 ±  0.03  15.36 ±  6.56 
[B6 ~  B6] (2)  8.48 4- 1.33  2.47 -I- 0.04  48.26 ±  7.24  35.44 ±  10.00 
[B6---~ AKR] (5)  7.20 ±  2.67§  2.65 +  1.06  47.81 ±  12.16§  33.79 ±  13.31 
* Number of animals in each group. 
:1: Data are shown as mean __- SD. 
§ NK and ADCC activities of chimeras are not significantly different from those  of normal AKR or B6 
mice (P >  0.05). 
To determine whether the secondary  PFC  responses  in the [B6 ~  AKR]  chimeras 
were reflecting an influence of AKR  cells, the responses were compared  in unmanip- 
ulated  spleen  cells and  in  spleen  cells treated  with  anti-H-2 k or anti-H-2 b antibody 
plus complement.  Such cytotoxic antibody  treatment  would eliminate all AKR  cells 
or,  alternatively,  cells  of the  B6  donor  origin  (Table  IV,  footnote).  The  anti-H-2 k 
treatment  failed  completely  to  alter  the  capacity  of the spleen  cells of the  chimeric 
mice  to  produce  either  direct  or  indirect  plaques  in  the  secondary  response.  By 
contrast, treatment  with anti-H-2 b antiserum almost completely inhibited capacity to 
produce  direct  PFC  and  very much  reduced  capacity  to  form  indirect  PFC  (Table 
IV). 
Primary  Responses  to  SRBC  of  Additional  H-2-Compatible  and  -Incompatible 
Combination.  To  determine  whether  the  results  presented  in  the  previous  section 
showing  complete  failure  of primary  immune  response  in  [B6 ~  AKR]  irradiation 
chimeras  were a  more general case and  based  upon  genetic differences of donor and 
recipient at MHC,  an additional  set of experiments were performed. After lethal total 
body  irradiation,  mice of AKR  or  B6  strains  were  reconstituted  by  treatment  with 124  IMMUNE RESPONSES  IN  FULLY ALLOGENEIC CHIMERA 
TABLE  IV 
Anti-SRBC PFC Response in Chimeras* 
Group  Direct PFC per  Indirect PFC per 
spleen  spleen 
Primary~: 
AKR (10)[[  50,295 ±  9,004¶  57,762 +  10,298 
B6 (10)  39,488 +  14,372  35,122 +  11,402 
[AKR ~  AKR] (5)  62,634 +  3,610  54,697 +  7,177 
[B6----~ AKR] (9)  156 ±  137"*  256 ±  174~: 
Secondary§ 
AKR (4)  1,489 +  630  89,640 --- 10,688 
B6 (5)  5,733 +  1,211  106,862 +  34,469 
[AKR---* AKR] (3)  4,457 ±  2,385  94,147 +  43,214 
[B6 ~  B6] (6)  13,856 ±  3,747  170,515 +  21,385 
[B6 ~  AKR] (9)  15,626 +  3,018§§  50,889 +  8,63711 II 
[B6 ---) AKR] (4) 
nontreated  14,412 +  1,886  56,753 +  19,889 
Treated with¶¶ anti-H-2  k and  12,996 +  5,566  56,697 +  25,621 
complement 
treated with***  anti-H-2  b and  167 +- 27  5,154 _+ 1,730 
complement 
*  Data pooled from three separate experiments. 
~:  4 d after immunization with 0.2 ml of 10% SRBC. 
§  4 d after reimmunization, which was given 9 d after primary immunization. 
II  Number of animals in each group. 
¶  Mean +  SE. 
**  Significantly lower than any other groups,  P <  0.01. 
~:~:  Significantly lower than any other groups,  P <  0.025. 
§§  Significantly higher than AKR, B6, and [AKR ~  AKR], P <  0.025. 
II]l  Significantly lower than AKR, B6, and [B6 --~ B6], P <  0.05. 
¶¶  1 ×  107/ml  spleen  cells were incubated  with  the same  volume of (1:200) anti-H-2  k 
antibody and (1:8) selected rabbit complement at 37°C for 45 min. After washing three 
times, cells were assayed for PFC. The number of PFC of normal AKR spleen cells was 
suppressed  98% (direct) and 76% (indirect)  by this treatment. 
*** 1 ×  107/ml  spleen  cells  were  incubated  with  the  same  volume of  (1:40) anti-H-2  b 
antiserum and (1:4) guinea pig complement. The number of PFC of normal B6 spleen 
cells was suppressed  99% (direct)  and 70% (indirect)  by this treatment. 
bone marrow  from AKR  or B6 donors  that  had  been treated  in vitro with anti-Thy- 
1  serum  ([AKR  ~  AKR],  [AKR  ---)  B6],  [B6  ~  AKR]).  Alternatively,  lethally 
irradiated  AKR  mice  were  treated  with  anti-Thy-1  serum-treated  marrow  from  E k 
congenic  mice, which  are  B6  background  but  have  H-2 k haplotype  instead  of H-2 b 
([E  k  ~  AKR]).  80  d  after  successful  bone  marrow  transplantation  that  did  not 
produce  evidence  of  acute  GVHR,  the  mice  were  stimulated  with  SRBC.  PFC 
responses  of spleen  cells were  analyzed  4  d  later.  The  [E  k ~  AKR]  H-2-compatible 
chimeric  mice were  regularly  shown  to  be  full  chimeras  because  their  thymus  cells 
were entirely of donor origin  (Table V, footnote). 
The  results summarized  in Table  V  show conclusively that  in each  instance when 
the bone marrow cells are from donors  histocompatible  with the recipients at  the H- 
2  locus,  the  primary  immune  response  shows  numbers  of both  direct  and  indirect 
plaques equal to or approaching  those of the unmanipulated  B6 or AKR  controls.  In 
every instance  where  donor  and  recipient  were  incompatible  at  the  H-2  locus,  both ONOI~,  FERNANDES,  AND GOOD 
TABLE  V 
Primary  Anti-SRBC PFC Response  in H-2-compatible Chimeras * 
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Group  Direct PFC per  Indirect PFC per 
spleen  spleen 
AKR (3):]:  80,980  ±  20,944  34,935  ±  5,989 
B6 (3)  33,824  ±  7,787  12,928 ±  5,990 
[AKR--* AKR] (4)  44,817  ±  4,916  18,651 ±  3,809 
[AKR -* B6]§  (2)  232 +  88  20 ±  20 
[B6~  AKR] (3)  97 ±  72  0 ±  0 
[EUl ---~ AKR] (3)  31,543  ±  4,171¶  11,714 +  4,482¶ 
* 4 d after immunization with 0.2 ml of 10% SRBC. 
:l: See Table IV, footnote 11. 
§ 25  X  108  anti-Thy-l.1  antiserum  (1:5)  treated  AKR  bone  marrow cells 
transplanted into lethally  irradiated  (900  rads)  B6  mice.  Spleen cells  from 
both chimeras showed >90% H-2  k (+). 
11B6-H-2k congenic  mice.  Chimerism  tested  by  analyzing only  thymocytes, 
because anti-H-2 serum was unavailable in this combination. Each chimera 
showed Thy-l.2 (+) cells 93,  >  95,  and >  95%; Thy-l.l(+) cells  0, <  5, and 
<5%, respectively. 
¶ Significantly higher than [AKR ~  B6] and [B6 ~  AKR], P <  0.01. 
TABLE  VI 
CS and Tolerance Induction  to DNFB in Chimeras * 
Group  DNBS  DNFB  Ear swelling 
C?/1-3 
AKR 
(6):~  --  --  1.29 -4- 0.89§ 
(8)  -  +  12.06 ±  2.30 
(6)  +  +  1.88 +  1.28 
[AKR ~  AKR] 
(5)  -  +  8.15  4- 2.89 
(5)  +  +  1.45 +  0.86 
B6 
(7)  -  -  2.07 +  1.17 
(6)  -  +  8.96  4-  1.88 
(6)  +  +  1.46 ±  0.94 
[B6---,B6] 
(3)  -  +  9.50 ±  2.12 
(3)  +  +  1.50 ±  0.71 
[B6 ~  AKR] 
(6)  -  --  1.81 +  1.26 
(6)  -  +  9.27  4- 4.20 
(6)  +  +  9.21  4- 3.26 
[E  kl~ -.~ AKR  l 
(4)  --  +  7.19 ±  2.83 
(3)  +  +  1.17 ±  0.68 
* Data pooled from two separate experiments. 
:~ The number in parentheses represents the number of animals in each group. 
§ Mean +  SD. 
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direct and indirect plaque-forming responses were negligible. These findings supple- 
ment those of the prior experiment in establishing that in full chimeras the primary 
antibody response to thymus-dependent SRBC antigen requires histocompatibility at 
MHC between donor and recipient. 
Contact Sensitivity  and Specific Unresponsiveness to  Contact Sensitivity  in  [B6 -*  AKR] 
Chimeras.  To  investigate interactions  of the  immunocompetent  cells  and  the  host 
cells or cellular components, an analysis was carried out  of the capacity of the  [B6 
AKR]  chimeras to develop and express contact sensitivity  (CS)  to DNFB,  using 
the ear swelling technique of Phanuphak et al. (30).  Representative data are presented 
on Table VI.  It can be seen from the  table that  vigorous capacity to develop and 
express CS was present in the long-lived [B6 ~  AKR] mice. Indeed this form of cell- 
mediated  immunity  was  as  vigorous  in  these  chimeras  as  in  AKR,  B6,  [AKR 
AKR], [B6 ~  B6], or [E  k ~  AKR] mice. 
Analyses to evaluate capacity to produce specific tolerance to DNFB by intravenous 
administration  of DNBS  before the sensitizing application  of DNFB  gave different 
results. The [B6 ~  AKR] chimeras appeared to be completely unable to develop the 
specific unresponsiveness  to  stimulation  with  DNFB  by the  intravenous  route.  By 
contrast, irradiated B6 mice or AKR mice reconstituted with syngeneic marrow cells 
([B6  ~  B6],  [AKR  ~  AKR])  or  irradiated  AKR  mice  reconstituted  with  H-2- 
compatible marrow cells  ([E  k ~  AKR])  developed specific unresponsiveness to the 
sensitization by DNFB applied to the skin as did the mice of B6 and AKR donor and 
recipient strains.  These findings establish that  [B6 ~  AKR] mice respond poorly to 
this form of tolerance induction, desensitization, or immunization. 
Discussion 
In these studies we present a reproducible method for preparing long-lived alloge- 
neic  chimeras  where  donor  and  recipient  mice  differ  from one  another  across  the 
major histocompatibility barrier, H-2. In the strain combination used, B6 donor and 
AKR recipient, which represents a  strain combination with strong hybrid resistance 
to bone marrow transplantation  (10),  the allogeneic chimeras [B6 ~  AKR] showed 
no  evidence  of GVHR  when  the  marrow  cells  had  been  treated  in  vitro  before 
injection by a potent anti-Thy-1.2 antisera in the absence of complement. By contrast, 
control  mice given allogeneic marrow not so treated regularly survived longer than 
irradiated controls, but most of them died before 50 d with evidence of GVHR. From 
studies  of the thymus and spleen  ceils it could be shown  that  these chimei"ic AKR 
mice possessed  virtually  all  B6  (H-2  b)  lymphocytes but  no cells  with  AKR  (H-2  k) 
surface antigens. The Thy-l.2 antigen of the B6 donor T-cell type was present on the 
thymus cells, and an appropriate portion of the spleen cells and no evidence of Thy- 
1.1  (+)  cells of AKR recipient  origin  could  be demonstrated.  Thus these were  full 
chimeras.  The  [B6  ~  AKR]  chimeras  were  shown  to  be  tolerant  of donor  and 
recipient  alloantigens by the Simonsen assay  (25)  and nearly fully reactive to third 
party alloantigens as revealed by the ability of their spleen cells to produce spleno- 
megaly  in  (B6  ×  BALB/c)F1  recipients.  However,  a  slightly  diminished  response 
toward third party antigens was seen  (Fig.  2), which may have been attributed  to a 
small deficiency of T-cell numbers in the spleen (Table I). 
Interestingly, the tolerance observed appeared to be of classic type, probably based 
on clonal inhibition or deletion  (31)  and not on a suppressor cell mechanism because ONOI~, FERNANDES, AND GOOD  127 
the spleen cells of these chimeras did  not suppress the ability of the normal spleen 
cells from B6 or AKR donors to initiate GVHR in (B6 ×  AKR)F1 mice. To establish 
the absence of suppressor cells convincingly,  further studies  in search  of suppressor 
cells  function  may be necessary in  experiments  that  use higher  proportions  of the 
spleen cells from the chimeras, because in the analysis carried out here, only one ratio 
of the mixture of spleen cells from the chimera and normal B6 or AKR mice was used 
and a  higher ratio might show evidence of suppressor cells, as reported by Urso and 
Gengozian (32). In addition, other kinds of analyses (e.g., mixed lymphocytes reaction, 
cell-mediated lympholysis [33])  of suppressor influence should also be carried out. 
Spleen  cells  from  these  fully  allogeneic  chimeras  were  also  able  to  demonstrate 
vigorous proliferative responses to PHA, Con A, and LPS stimulations in vitro. Thus, 
they had well-developed populations of both T  and B lymphocytes that showed little 
or no evidence of being suppressed. Because some of these responses require T  cell-T 
cell  interactions  (34)  or  interactions  of T  cells with  cells of monocyte-macrophage 
lineage  (35),  these chimeric mice appeared to have interaction  of monocyte-macro- 
phage  lineage  and  the  T  lymphocytes  sufficient  to  permit  normal  proliferative 
response to Con A, PHA, and LPS. This is, however, a somewhat controversial issue 
since McCombs et al. (36)  reported that histocompatibility between lymphocyte and 
macrophage is  not  a  requirement  for proliferative responses  to  mitogens.  NK and 
ADCC functions of these chimeric mice were also in normal range. 
Studies of the PFC responses to stimulation with SRBC are of special interest. No 
direct  or  indirect  PFC  responses  were  observed  upon  primary  stimulation.  This 
limitation was seen in  [B6 ~  AKR] and [AKR ---* B6]  chimeras, whereas it was not 
seen with  [AKR ~  AKR]  preparations or when  E k congenic mice were the donors 
[E  k ~  AKR]  (Table V). 
Thus, the primary responses in these fully chimeric mice where mature T  cells have 
been eliminated from the precursors used for immunologic and hematopoietic recon- 
struction are deficient in T-dependent antibody formation as might be predicted from 
studies of genetic restriction previously reported  (1,  2, 5, 37).  Nonetheless, strikingly 
vigorous responses of antibody-forming cells to the T-dependent antigen were observed 
for both IgM- and IgG-type plaque formation during a secondary response in the [B6 
AKR] chimera (Table IV). The indirect  plaque formation was somewhat lower 
and the direct PFC responses considerably higher than were seen with the B6, AKR, 
or [AKR ~  AKR] controls.  However, even the mice reconstituted  after lethal total 
body irradiation by syngeneic marrow cells showed in the secondary response some- 
what  higher IgM plaques than  did either donor or recipient strain.  Thus,  it would 
appear that  although some degree of aliogeneic preference or restriction  in  indirect 
PFC  response  may be  obtained  in  these  chimeric  mice,  it  is  not  as  limiting  with 
respect to secondary T-dependent antibody responses as might be extrapolated from 
the existing literature  (1-3, 5, 6,  11-13, 37-39).  It seems to us that these findings are 
concordant with prior observations by Gengozian et al. (40), von Boehmer et al. (41), 
Erb et al. (42), Hong et al. (43), and Katz et al. (44), which suggest that the restrictions 
are not absolutely binding if there is opportunity for prior experience and a period for 
learning. 
The studies  of CS  in  these  fully allogeneic chimeras were also  most  fascinating. 
Skin reactions after sensitization with DNFB were not different from those of normal 
mice or of irradiated mice reconstituted with syngeneic bone marrow cells. This was 128  IMMUNE RESPONSES IN FULLY ALLOGENEIC CHIMERA 
somewhat  surprising  since  Miller  et  al.  (45)  showed  that  identity  at  the  MHC  is 
necessary for passive transfer of delayed type hypersensitivity to DNFB and Asherson 
et  al.  (46)  reported  that  active immunization  with  a  small  number of lymph node 
cells from donors immunized with contact sensitizer (oxazolone) 24 h before injection 
occurred only when a  genetic matching at MHC between donor and recipient mice 
existed.  These  results,  however, are  also somewhat  controversial,  and  our  findings 
clearly indicate that vigorous CS to DNFB can occur when a state of full chimerism 
exists in which the lymphoid cells are of donor origin and the skin cells of host origin. 
Recent  evidence suggests that  Langerhans  cells of the skin  may play an  important 
role in the development of CS because they can absorb certain antigens and possess 
Ia antigens  and  Fc receptors  (47-49).  It  thus  seems important  to know  if in  these 
chimeras the Langerhans cells are of donor or host origin. This should be studied. 
By contrast to the observations with CS, desensitization, or tolerization by intra- 
venous  injection  of  DNBS  was  ineffectual  in  preventing  CS  to  DNFB  in  these 
allogeneic chimeras but was fully effective in the lethally irradiated mice reconstituted 
with syngeneic or H-2-compatible marrow cells. Whether or not the rather complex 
tolerance in intact animals, which  is known to depend in part on T-suppressor cells 
(50),  augmenting  cells  for  the  T-suppressor  cells  (51),  and  even  classical  clonal 
inhibition  (50,  52)  can be developed in fully allogeneic chimeras by repeated stimu- 
lation with DNBS remains to be determined in future studies. 
Because our experiments appear to lend an optimistic prespective to the possibility 
of cellular engineering (19) employing allogeneic cells differing from host across major 
histocompatibility barrier it will be of interest to know whether, in this model and in 
those  employed  by  Miiller-Ruchholtz  et  al.  (14)  with  rats,  or  that  of Truitt  and 
Pollard  (15) with mice, truly long-lived [B6 ~  AKR] mice can be obtained that can 
resist bacterial and viral infections normally. Experiments to address these important 
questions with fully allogeneic chimeras seem in order. One would surely predict from 
the  most  recent  experiments  of Zinkernagel  et  al.  (2,  3) 2 that  the  T  lymphocyte 
developing in contact with the thymus epithelium of the recipients would be able to 
address the host-virus-infected somatic cells with normal immunologic vigor. It will 
be especially important to know whether allogeneic cells prepared with antiserum to 
eliminate T  cells from marrow after a  gentle manipulation,  such  as was used here, 
can  resist  the  malignancies  caused  by  virus  or  chemical  carcinogens.  The  AKR 
recipients  thus  seem to be an especially good  model  for further  inquiries  into  the 
effectiveness of the cellular and  immunologic reconstitution  after lethal  irradiation 
and  bone  marrow  transplantation  made  possible  by  treatment  to  eliminate  post 
thymic cells with anti-Thy-1 serum in vitro. 
Whether  similar results  will be obtained  with  other strain  combinations in  mice 
remains to be seen.  Additional  investigations in our own laboratories establish that 
long-lived, immunologically vigorous chimeras B6 --* CBA may be produced  if the 
marrow cells are pretreated with appropriate anti-Thy- 1 plus complement (S. Krown, 
R. Colco, G. Fernandes, and R. A. Good. Unpublished data.) This is the same genetic 
barrier studied  in our experiments and is usually considered to be among the most 
resistant to allogeneic transplantation. Whether the preparatory treatment with anti- 
2 Zinkernagel, R. M., and P. C. Doherty. MHC-restricted  cytotoxic  T cells: studies on the biological role 
of the polymorphic major transplantation antigens determining T-cell restriction-specificity  function and 
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Thy-1 without complement has advantage over the preparatory treatment with anti- 
Thy-1 plus complement will have to be ascertained by direct comparative analyses of 
the two methods. That pretreatment with anti-Thy-1 serum without complement is 
effective, as shown herein, is of great importance because so many of the sources of 
complement one would like to use are also cytotoxic to the stem cells that one does 
not wish to damage. 
Summary 
AKR  mice were protected  from  lethal  irradiation  and  established  as  long-lived 
chimeras  by  transplanting  allogeneic C57BL/6  (B6)  bone  marrow  that  had  been 
treated in vitro with anti-Thy-1 antiserum without complement. In these chimeras, 
which were designated [B6 ~  AKR], virtually all the thymus and spleen cells were 
shown to be derived from the B6 donor; several immune functions studied in these 
chimeras were as follows:  (a) The chimeric mice were tolerant of histocompatibility 
antigens of both donor and recipient strain and nearly fully reactive to antigens of 
third party, as revealed by Simonsen's splenomegaly assay.  The tolerance of these 
chimeras could not be attributed to suppressor cells but was compatible with clonal 
depletion.  (b)  Proliferative responses  to concanavalin  A,  phytohemagglutinin,  and 
lipopolysaccharide as well  as  natural  killer and  antibody-dependent cell-mediated 
cytotoxicity activity of the chimeric mice was normal. (c) Plaque-forming cell (PFC) 
assays of antibody responses to sheep erythrocytes (SRBC) showed gross deficiency in 
the primary response of the [B6 ~  AKR] and [AKR ~  B6] chimeras. 
By contrast, [B6-H-2k(E  k) --~ AKR] H-2-compatible chimeras and [AKR ----) AKR] 
syngeneic  marrow  transplanted  mice  had  normal  primary  PFC  responses.  PFC 
responses after secondary stimulation with SRBC, however, revealed vigorous direct 
plaque formation and substantial but somewhat smaller indirect plaque formation in 
the  [B6 ----) AKR]  chimeras.  This observation  favors operationally the  concept of 
adaptive differentiation proposed by Katz et al.  (44).  (d)  Analysis of ability of the 
chimeras to develop and express delayed-type hypersensitivity responses to contact 
sensitizer  (2,4-dinitro-l-fluorobenzene  [DNFB])  showed  no  apparent  immunodefi- 
ciency of either chimeras to this form of immunization. Development of immunologic 
tolerance to  DNFB,  however, was  grossly deficient in  [B6 ~  AKR]  chimeras but 
normal in [AKR ~  AKR], [B6 ~  B6], and [E  k ~  AKR] chimeras. 
These findings indicate that full chimeras across major histocompatibility complex 
have considerable immunologic vigor even though primary immune responses that 
require histocompatibility between interacting cell types are initially defective. 
The authors gratefully acknowledge  the skillful  technical assistance  of Gerald Vogel,  Fred 
Barreau, and Glenda McFeeters. 
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